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Rredicting the Effectiveness
f Beta-Blocker Therapy
n Vasovagal Syncope
here has been a great deal of interest in the therapeutic role of
eta-adrenergic blockade in patients suffering from vasovagal
yncope. The efficacy of beta-blockers in these patients may be due
o blunting of elevated catecholamine levels that precede vasovagal
yncope (1). Notwithstanding the widespread use of beta-blockers
n the past, some studies on chronic beta-blocker use have been less
han encouraging and may suggest some benefit in older but not in
ounger patients, as mentioned in the recent article by Tan and
arry (2). That being said, might there be a better way to predict
he favorable use of beta-blocker therapy in patients suffering from
asovagal syncope? In one study of patients with confirmed
asovagal syncope, all patients with a negative tilt test response
uring esmolol infusion had a negative tilt test response with oral
etoprolol. Of the remaining patients with a positive tilt test
esponse during esmolol infusion, 90% continued to have a positive
esponse with oral metoprolol (3). In another study, a negative test
ith esmolol infusion among 112 patients with vasovagal syncope
as again found to be an independent predictor for prevention of
ymptoms with oral metoprolol during follow-up of 2.7  1.2
ears (p  0.0001) (4). Those authors concluded that “acute
hallenge with esmolol infusion appears to be an accurate predictor
f response to chronic beta-blockers.” A negative head-up tilt test
uring propanolol infusion was similarly found to predict favorable
esponses to oral beta-blocker therapy in other studies, including a
rospective trial of 296 patients (5–7). Thus, data on the effec-
iveness of a beta-blocker challenge during the head-up tilt test in
atients with vasovagal syncope may be very helpful in formulating
 therapeutic strategy.
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eply
e thank Dr. Kapoor for his interest in our recent paper (1). As
entioned by Dr. Kapoor, beta-blockers had indeed found wide-
pread usage in the treatment of vasovagal syncope in the past.
arlier uncontrolled studies (2,3) and 1 small randomized-
ontrolled study (4) had demonstrated encouraging results, fueling
his practice. However, recent randomized controlled trials (5,6),
s well as the only multicenter, randomized, placebo-controlled
rial published to date (7), have failed to demonstrate any beneficial
ffects with beta-blockers. There was a statistically nonsignificant
rend to benefit in the subgroup of subjects 42 years of age,
uggesting that further evaluation of the use of beta-blockers in
lder subjects may be warranted (8).
The studies cited by Dr. Kapoor were uncontrolled studies
valuating the role of intravenous beta-blockers in predicting
reatment response to long-term oral beta-blocker therapy. Fol-
owing the positive diagnosis of vasovagal syncope with a head-up
ilt (HUT) test, a second HUT was performed to assess response
o intravenous esmolol or propanolol (9–11). However, there has
een a reasonable body of evidence demonstrating that the
eproducibility of a positive HUT is low (12–15). The role of
UT as an instrument to evaluate treatment benefit is therefore
imited, and can only be used in this context if a comparison is
ade with placebo (16).
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